ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. SMD Rise PCL's annualized net income for the quarter that ended in Mar. 2026 was ฿-122.2 Mil. SMD Rise PCL's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ฿700.7 Mil. Therefore, SMD Rise PCL's annualized ROE % for the quarter that ended in Mar. 2026 was -17.44%.
The historical rank and industry rank for SMD Rise PCL's ROE % or its related term are showing as below:
BKK:SMD100-R'
s ROE % Range Over the Past 10 Years
Min: 0.94 Med: 28.61 Max: 57.12
Current: 0.94
During the past 8 years, SMD Rise PCL's highest ROE % was 57.12%. The lowest was 0.94%. And the median was 28.61%.
BKK:SMD100-R's ROE % is ranked worse than 76.52% of 115
companies
in the Medical Distribution industry
Industry Median: 7.1
vs BKK:SMD100-R: 0.94
SMD Rise PCL (BKK:SMD100-R) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
SMD Rise PCL ROE % Related Terms
SMD Rise PCL ROE % Historical Data
* Premium members only.
The historical data trend for SMD Rise PCL's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, SMD Rise PCL's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMD Rise PCL ROE % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's ROE % distribution charts can be found below:
* The bar in red indicates where SMD Rise PCL's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
SMD Rise PCL (BKK:SMD100-R) has a ROE % of -17.44% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on SMD Rise PCL and its competitors. Over the past decade, SMD Rise PCL's ROE % has ranged from 0.94 to 57.12. According to the industry distribution chart, SMD Rise PCL ranks #88 out of 115 companies in the Medical Distribution industry, placing it in the top 76.5%.
Is SMD Rise PCL's ROE % too high?
SMD Rise PCL's current ROE % is -17.44%. Over the past 10 years, this metric has ranged from a low of 0.94 to a high of 57.12. Based on the distribution chart, SMD Rise PCL ranks #88 out of 115 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, SMD Rise PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's ROE % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #88 out of 115 companies for ROE %. This places SMD Rise PCL in the lower half of its industry. The industry median ROE % is 7.10. Historically, SMD Rise PCL's own ROE % has ranged from 0.94 to 57.12 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Distribution company?
The median ROE % among Medical Distribution companies is 7.10, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on SMD Rise PCL and its competitors. For the Medical Distribution industry, the median ROE % is 7.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current ROE % is -17.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current ROE % of -17.44%. The stock's GF Value™ is ฿23.66, compared to a current price of ฿5.85 — trading 75.3% below its estimated fair value. The current ROE % is -17.44%. SMD Rise PCL's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current ROE % is -17.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿5.85 is trading 75.3% below its estimated GF Value™ of ฿23.66.
Key valuation signals for BKK:SMD100-R:
ROE %: -17.44%
GF Value™: ฿23.66 vs. price of ฿5.85 (75.3% below fair value)
No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
59GF Score
Get the complete analysis for BKK:SMD100-R
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100-R has been successfully added to your 
